LOCUS PHARMACEUTICALS

Locus Pharmaceuticals, Inc. develops a drug design and development platform for oral drug therapies in the areas of unmet medical needs. Its fragment-based computational drug design technology is used for the discovery and development of compounds for the treatment of unmet medical needs. The company has a computational drug design technology, which is used to develop a pipeline of drug development candidates, including direct and allosteric kinase inhibitors for cancer and inflammation diseases. Locus Pharmaceuticals, Inc. was formerly known as Locus Discovery, Inc. The company was incorporated in 1998 and is based in Blue Bell, Pennsylvania. Locus Pharmaceuticals, Inc. is a former subsidiary of Sarnoff Corporation.
LOCUS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1998-01-01
Address:
Blue Bell, Pennsylvania, United States
Country:
United States
Website Url:
http://www.locuspharma.com
Total Employee:
11+
Status:
Closed
Contact:
1-888-600-4908
Email Addresses:
[email protected]
Total Funding:
139.63 M USD
Technology used in webpage:
SPF DMARC Digital Ocean GoDaddy Email Mandrill DNS Made Easy DNS SparkPost
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2004-07-21 | Protein Mechanics | Protein Mechanics acquired by Locus Pharmaceuticals | N/A |
Investors List
L Capital Partners
L Capital Partners investment in Series E - Locus Pharmaceuticals
SR One
SR One investment in Series E - Locus Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series E - Locus Pharmaceuticals
Tredegar Investments
Tredegar Investments investment in Series C - Locus Pharmaceuticals
Cooper Hill Partners
Cooper Hill Partners investment in Series C - Locus Pharmaceuticals
Prism Venture Management
Prism Venture Management investment in Series C - Locus Pharmaceuticals
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Locus Pharmaceuticals
Delphi Ventures
Delphi Ventures investment in Series C - Locus Pharmaceuticals
Dresdner Kleinwort
Dresdner Kleinwort investment in Series C - Locus Pharmaceuticals
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Locus Pharmaceuticals
Official Site Inspections
http://www.locuspharma.com
- Host name: box.irsa-uscr.org
- IP address: 138.197.162.211
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
